Rosa Viana

Valencia, VC 46010, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

An astrocytic cellular model of Lafora disease to study polyglucosan accumulation and inflammation.

An astrocytic cellular model of Lafora disease to study polyglucosan accumulation and inflammation.

Journal: Disease models & mechanisms

Published: September 17, 2025

A novel Lafora disease astrocytic cellular model to study polyglucosan accumulation and inflammation.

A novel Lafora disease astrocytic cellular model to study polyglucosan accumulation and inflammation.

Journal: Disease models & mechanisms

Published: September 17, 2025

The biochemical dynamics of the glycogen phosphatase laforin directly impact brain metabolism.

The biochemical dynamics of the glycogen phosphatase laforin directly impact brain metabolism.

Journal: The Journal of biological chemistry

Published: June 02, 2025

Glial Alterations in the Glutamatergic and GABAergic Signalling Pathways in a Mouse Model of Lafora Disease, a Severe Form of Progressive Myoclonus Epilepsy.

Glial Alterations in the Glutamatergic and GABAergic Signalling Pathways in a Mouse Model of Lafora Disease, a Severe Form of Progressive Myoclonus Epilepsy.

Journal: Neuropathology and applied neurobiology

Published: October 21, 2024

Glial alterations in the glutamatergic and GABAergic signaling pathways in a mouse model of Lafora disease, a severe form of progressive myoclonus epilepsy.

Glial alterations in the glutamatergic and GABAergic signaling pathways in a mouse model of Lafora disease, a severe form of progressive myoclonus epilepsy.

Journal: bioRxiv : the preprint server for biology

Published: September 24, 2024

Severe acute respiratory syndrome coronavirus-2 accessory proteins ORF3a and ORF7a modulate autophagic flux and Ca2+ homeostasis in yeast.

Severe acute respiratory syndrome coronavirus-2 accessory proteins ORF3a and ORF7a modulate autophagic flux and Ca2+ homeostasis in yeast.

Journal: Frontiers in microbiology

Published: January 27, 2023

TNF and IL6/Jak2 signaling pathways are the main contributors of the glia-derived neuroinflammation present in Lafora disease, a fatal form of progressive myoclonus epilepsy.

TNF and IL6/Jak2 signaling pathways are the main contributors of the glia-derived neuroinflammation present in Lafora disease, a fatal form of progressive myoclonus epilepsy.

Journal: Neurobiology of disease

Published: November 02, 2022

An empirical pipeline for personalized diagnosis of Lafora disease mutations.

An empirical pipeline for personalized diagnosis of Lafora disease mutations.

Journal: iScience

Published: August 10, 2021

Endocytosis of the glutamate transporter 1 is regulated by laforin and malin: Implications in Lafora disease.

Endocytosis of the glutamate transporter 1 is regulated by laforin and malin: Implications in Lafora disease.

Journal: Glia

Published: July 31, 2020

Regulation of the autophagic PI3KC3 complex by laforin/malin E3-ubiquitin ligase, two proteins involved in Lafora disease.

Regulation of the autophagic PI3KC3 complex by laforin/malin E3-ubiquitin ligase, two proteins involved in Lafora disease.

Journal: Biochimica et biophysica acta. Molecular cell research

Published: July 15, 2019

In vivo glutamate clearance defects in a mouse model of Lafora disease.

In vivo glutamate clearance defects in a mouse model of Lafora disease.

Journal: Experimental neurology

Published: January 31, 2019

A novel EPM2A mutation yields a slow progression form of Lafora disease.

A novel EPM2A mutation yields a slow progression form of Lafora disease.

Journal: Epilepsy research

Published: June 01, 2018

Showing 1-12 of 20

Last Updated: 09/26/2026